TSE:KPT KP Tissue (KPT) Stock Price, News & Analysis C$7.94 -0.02 (-0.25%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades About KP Tissue Stock (TSE:KPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KP Tissue alerts:Sign Up Key Stats Today's RangeC$7.84▼C$7.9850-Day RangeC$7.80▼C$8.2652-Week RangeC$7.66▼C$9.05Volume15,463 shsAverage Volume13,927 shsMarket CapitalizationC$79.35 millionP/E Ratio12.43Dividend Yield9.07%Price TargetC$9.13Consensus RatingHold Company OverviewKP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Metro, White Swan, White Cloud, Embassy, Satinelle, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.Read More… KP Tissue Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreKPT MarketRank™: KP Tissue scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingKP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageKP Tissue has received no research coverage in the past 90 days.Read more about KP Tissue's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of KP Tissue is 12.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.58.Price to Earnings Ratio vs. SectorThe P/E ratio of KP Tissue is 12.43, which means that it is trading at a more expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 10.82.Price to Earnings Growth RatioDue to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.Price to Book Value per Share RatioKP Tissue has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for KPT. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipKP Tissue is a leading dividend payer. It pays a dividend yield of 9.15%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthKP Tissue does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of KP Tissue is 112.73%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about KP Tissue's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for KPT. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for KP Tissue this week, compared to 1 article on an average week. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, KP Tissue insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$147,420.00 in company stock.Percentage Held by InsidersOnly 0.14% of the stock of KP Tissue is held by insiders.Percentage Held by InstitutionsOnly 8.61% of the stock of KP Tissue is held by institutions.Read more about KP Tissue's insider trading history. Receive KPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter. Email Address KPT Stock News HeadlinesCould Trump tariffs cause COVID-19-like run on toilet paper? Leading Canadian producer thinks soFebruary 14, 2025 | theglobeandmail.com3 Canadian Dividend Stocks to Consider Adding to Your TFSA in 2025January 14, 2025 | msn.comElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.February 22, 2025 | True Market Insiders (Ad)KP Tissue Inc.: KP Tissue Releases Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deKP Tissue announces senior note financing to redeem previous onesOctober 28, 2024 | msn.comKP Tissue Expands with New Sherbrooke PlantOctober 22, 2024 | markets.businessinsider.comKP Tissue Inc.: KP Tissue Releases Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deKP Tissue Inc. (KPTSF) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comSee More Headlines KPT Stock Analysis - Frequently Asked Questions How have KPT shares performed this year? KP Tissue's stock was trading at C$8.23 at the start of the year. Since then, KPT shares have decreased by 3.5% and is now trading at C$7.94. View the best growth stocks for 2025 here. How do I buy shares of KP Tissue? Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of KP Tissue own? Based on aggregate information from My MarketBeat watchlists, some other companies that KP Tissue investors own include Constellation Software (CSU), Intact Financial (IFC), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Wheaton Precious Metals (WPM) and Vermilion Energy (VET). Industry, Sector and Symbol Stock ExchangeTSE SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolTSE:KPT CUSIPN/A CIKN/A Webkptissueinc.com Phone+1-905-8126900FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$9.13 High Stock Price TargetC$10.00 Low Stock Price TargetC$8.50 Potential Upside/Downside+14.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.64 Trailing P/E Ratio12.43 Forward P/E Ratio18.05 P/E Growth-0.88Net IncomeC$6.38 million Net MarginsN/A Pretax MarginN/A Return on Equity9.05% Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio1.23 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$7.08 per share Price / Book1.12Miscellaneous Outstanding Shares9,994,200Free FloatN/AMarket CapC$79.35 million OptionableNot Optionable Beta0.37 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (TSE:KPT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KP Tissue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KP Tissue With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.